Procter & Gamble SEC Filings

Form 144 notice filed for Procter & Gamble (PG) reporting a proposed sale of 13,893 shares of common stock through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $2,113,194.77 and an approximate sale date of 10/02/2025. The filing shows the shares were acquired as a Restricted Stock Unit award on 10/03/2022 (28,235 units). It also discloses a prior sale by the same person of 40,119 shares on 08/19/2025 for gross proceeds of $6,309,667.58. The filer attests there is no undisclosed material adverse information and includes standard Rule 144 representations.

Procter & Gamble (PG) filed a Form 144 notifying the proposed sale of common stock by an insider. The notice lists two proposed transactions through Morgan Stanley Smith Barney totaling 2,680 shares with an aggregate market value of $407,641.40, each scheduled for 10/02/2025 on the NYSE. The securities were acquired as Restricted Stock Unit awards from The Procter & Gamble Company on 10/03/2022 (amounts: 874 and 4,070 units). The filing also discloses prior sales by the same person during the past three months totaling 11,463 shares that generated $1,812,976.84. The filer certifies no undisclosed material adverse information.

Form 144 notice for Procter & Gamble (PG) shows a proposed sale of 582 shares of common stock through Morgan Stanley Smith Barney on the NYSE with an approximate sale date of 10/02/2025 and an aggregate market value of $88,525.11. The securities were acquired as a Restricted Stock Unit award on 10/03/2022 from The Procter & Gamble Company, with 1,901 shares recorded as acquired. The filer previously sold 606 shares on 08/19/2025 for gross proceeds of $95,307.92. The filer affirms no undisclosed material adverse information about the issuer.

Form 144 notice for Procter & Gamble (PG) reports a proposed sale of 5,056 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $769,042.88. The filing states the securities were acquired as Restricted Stock Unit Awards on 10/03/2022 from The Procter & Gamble Company, and payment (if any) was recorded on the same date. The filer also disclosed an earlier sale by the same person of 11,638 shares on 08/19/2025 for gross proceeds of $1,830,352.48. The notice includes the required representation that the seller does not possess undisclosed material adverse information about the issuer.

Filing excerpt opposes shareholder proposals on plastics and ESG The document is a proxy-related submission addressing Procter & Gamble's consideration of plastics, recycling and circular-economy proposals. It argues that proponents are agenda-driven activists and cites multiple reports and sources to challenge claims that plastics production is the primary cause of ocean pollution or greenhouse-gas impacts. The filing contends that waste management and disposal, not production, drive plastic leakage into oceans and highlights studies it says show plastics can have lower life-cycle GHG emissions than alternatives. It urges P&G to rely on "scientifically rigorous and economically sensible" analysis rather than adopt activist-driven targets or packaging mandates.

Balaji Purushothaman, Chief Human Resources Officer of Procter & Gamble (PG), reported transactions on 09/15/2025. The filing shows a disposition of 13,106.0044 shares of common stock and an acquisition by exercise of a stock option (right to buy) for 11,420 shares with a stated exercise price of $156.83. The filing also discloses 5,112.6018 shares held indirectly through a retirement plan trustee. The Form 4 was signed by an attorney-in-fact on 09/17/2025.

Shailesh Jejurikar, Chief Operating Officer of Procter & Gamble Co (PG), reported transactions dated 09/15/2025. The filing shows a disposition of 28,036.3817 shares of Common Stock and the acquisition of a stock option award for 26,231 underlying shares with an exercise price of $156.83. The option award is listed as acquired on 09/15/2025, becomes exercisable on 09/15/2028 and expires 09/14/2035. The report lists indirect beneficial ownership stakes of 3,301.9815 shares held by a retirement plan trustee, 19,757 shares held by the Sankhya S Jejurikar Revocable Trust, and 17,849 shares held by the Shailesh Jejurikar Trust. The form is signed by an attorney-in-fact on 09/17/2025.

Reporting person: Aguilar Moses Victor Javier, Chief Research, Development & Innovation Officer at Procter & Gamble Co (PG). Transactions on 09/15/2025: the Form 4 discloses a disposition of 40,841.1704 shares of P&G common stock and continuing indirect holdings of 6,750.7456 shares held by a Retirement Plan Trustee and 428.6033 shares held by an International Stock Ownership Plan (Mexico) Trustee. The filing also reports an acquisition (transaction code A) of 6,852 stock options tied to 6,852 underlying common shares with a stated conversion/exercise price of $156.83 and a listed price of $0; the options show exercisability beginning 09/15/2028 and expiration 09/14/2035. The form is signed by an attorney-in-fact on behalf of Mr. Aguilar on 09/17/2025.

Procter & Gamble faces rising risks from its use of flexible plastic packaging. The filing highlights growing financial exposure if governments force producers to pay full waste-management costs, citing an estimated collective industry risk of $100 billion. Seven U.S. states have passed extended producer responsibility (EPR) laws that charge higher fees for hard-to-recycle materials. The company reported flexible packaging rising from 12.7% in 2021 to 19.6% in 2022, with unrecyclable multi-material flexibles at 14% and difficult-to-recycle mono-material flexibles at 5% (mono-material films rose from 0% to 5.2%). These gaps are presented as creating regulatory, financial, and reputational risk and as undermining P&G’s stated packaging goals.